Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of anti-thyroid drug withdrawal on iodine-123 kinetics before iodine-131 therapy in Graves disease
2012-003579-21Phase 4Active
- Sponsor
- Policlinico di Milano
- Start
- Nov 2012
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Gamma Emitters → Radiopharmaceuticals
- Countries
- 1
01
Overview
Phase 4, open-label trial of iodine-123 in Graves' disease and thyroid disease (2 arms), sponsored by Policlinico di Milano. Primary endpoint: Primary iodine-123 uptake differences at fixed time points. Started Nov 2012; status: active.
02
Drugs
iodine-123
03
Conditions
Graves' diseasethyroid disease
Beyond the preview
Go deeper on 2012-003579-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003579-21.